1. Home
  2. DRTS vs PTA Comparison

DRTS vs PTA Comparison

Compare DRTS & PTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$13.15

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest

PTA

Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest

HOLD

Current Price

$19.05

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRTS
PTA
Founded
2015
2020
Country
Israel
United States
Employees
121
N/A
Industry
Medical/Dental Instruments
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DRTS
PTA
Price
$13.15
$19.05
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$8.67
N/A
AVG Volume (30 Days)
553.0K
99.1K
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
8.31%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$699.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.01
$18.13
52 Week High
$14.11
$20.92

Technical Indicators

Market Signals
Indicator
DRTS
PTA
Relative Strength Index (RSI) 57.08 47.97
Support Level $11.24 $18.89
Resistance Level $14.00 $19.57
Average True Range (ATR) 0.80 0.16
MACD -0.02 0.01
Stochastic Oscillator 69.05 63.11

Price Performance

Historical Comparison
DRTS
PTA

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

About PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest

COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its main investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.

Share on Social Networks: